Skip to main content


  • Meeting abstract
  • Open Access

Uremia alters HDL composition and cholesterol efflux capacity

  • 1,
  • 2,
  • 3,
  • 1,
  • 1,
  • 4,
  • 1 and
  • 1Email author
BMC Pharmacology and Toxicology201213 (Suppl 1) :A15

  • Published:


  • Renal Disease
  • Functional Impairment
  • Lipid Composition
  • Cardiovascular Mortality
  • Uremia


Functional impairment of HDL may contribute to the excess cardiovascular mortality experienced by patients with renal disease, but the effect of advanced renal disease on the composition and function of HDL is not well understood.


Mass spectrometry and biochemical analyses were used to study alterations in the proteome and lipid composition of HDL isolated from patients on maintenance hemodialysis.


We identified a significant increase in the amount of acute-phase protein serum amyloid A1, albumin, lipoprotein-associated phospholipase A2, and apoC-III composing uremic HDL. Furthermore, uremic HDL contained reduced phospholipids and increased triglycerides and lysophospholipids. With regard to function, these changes impaired the ability of uremic HDL to promote cholesterol efflux from macrophages.


In summary, the altered composition of HDL in renal disease seems to inhibit the cardioprotective properties of HDL. Assessing HDL composition and function in renal disease may help to identify patients at increased risk for cardiovascular disease.



This work was supported by the Austrian Science Fund FWF (grants P21004-B02 and P22976-B18).

Authors’ Affiliations

Institute of Experimental and Clinical Pharmacology, Medical University of Graz, 8010 Graz, Austria
Proteomics Core Facility, Centre for Medical Research, Medical University of Graz, 8036 Graz, Austria
Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, 8036 Graz, Austria
Department of Obstetrics and Gynecology, Medical University of Graz, 8036 Graz, Austria


© Holzer et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.